China, Hong Kong - December 15, 2023 - Viva Biotech Holdings (1873.HK) announced that it will receive nearly US$15 million in financing, transferring about 2.33% of its stake in Viva Biotech (Shanghai) Limited. The transaction values Viva Biotech (Shanghai) at approximately 4.6 billion RMB. This round of investment marks ICD's first direct investment project in China, reflecting its full recognition of Viva Biotech's unique position in the global innovative drug discovery industry. Additionally, ICD's involvement will provide significant strategic support for Viva's global business development and help to further enhance synergies.
About Raed Capital Holdings 2：
Raed Capital Holdings 2 Ltd is a private company incorporated in the Dubai International Financial Centre of the United Arab Emirates and is wholly-owned by Investment Corporation of Dubai (“ICD”). ICD is the principal investment arm of the Government of Dubai. Established in 2006, ICD manages a broad portfolio of assets, both locally and internationally, across a wide spectrum of sectors that support Dubai’s dynamic economy.
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us